Celiprolol
- Generic Name
- Celiprolol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H33N3O4
- CAS Number
- 56980-93-9
- Unique Ingredient Identifier
- DRB57K47QC
- Background
Celiprolol is indicated for the management of mild to moderate hypertension and effort-induced angina pectoris. It is simultaneously a selective β1 receptor antagonist, a β2 receptor partial agonist and a weak α2 receptor antagonist. In 2010 a clinical trial has suggested a use for this medication in the prevention of vascular complications of a rare inherit...
- Indication
Celiprolol is indicated for the management of mild to moderate hypertension and effort-induced angina pectoris.
- Associated Conditions
- Angina Pectoris, Hypertension
- Associated Therapies
- -
Celiprolol Versus Ditiazem for the Prevention of Postoperative Cardiac Arrythmias in Thoracic Surgery
- First Posted Date
- 2018-11-26
- Last Posted Date
- 2018-11-26
- Lead Sponsor
- Abderrahmane Mami Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03752931
- Locations
- 🇹🇳
Hospital Abderrahmane Mami, Ariana, Tunisia
Chronic Beta-blockade and Cardiopulmonary Exercise in COPD
- Conditions
- Interventions
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2019-06-24
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 10
- Registration Number
- NCT02380053
- Locations
- 🇬🇧
Asthma and Allergy Research Group, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom
Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
- Conditions
- Interventions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2013-01-16
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 54
- Registration Number
- NCT00190411
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.